Investorideas.com - (CSE: $VRT.C) (OTC: $VRTHF) News: US Patent Office Acknowledges Provisional Patent Application for Use of Specific #Cannabis Strain to Enhance Opioid Analgesia

Investorideas.com - (CSE: $VRT.C) (OTC: $VRTHF) News: US Patent Office Acknowledges Provisional Patent Application for Use of Specific #Cannabis Strain to Enhance Opioid Analgesia

Veritas Pharma Inc. (CSE: VRT; OTC:
VRTHF;
and Frankfurt: 2VP), (“Veritas” or the “Company”) announces its research arm,
Cannevert Therapeutics Ltd. (“CTL”) filed a provisional patent application to
US Patent and Trademark Office (the “USPTO”) on September 13, 2017 for use of a
specific cannabis strain to enhance the actions of opioid analgesics.  An acknowledgement letter from the USPTO was
received recently which provided a filing number of US 62/558,021 for this
application.

Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis

Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis

Stocks Mentioned: Veritas Pharma Inc. (CSE: $VRT.C;
OTC: $VRTHF), Zynerba (NASDAQ:  $ZYNE), GW Pharmaceuticals
(NASDAQ:  $GWPH), Tetra Bio-Pharma (TSXV:
$TBP.V; $TBPMF), Aphria Inc (TSX: $APH.TO; 
$APHQF)

Point Roberts, WA, November 21, 2017 –
Investorideas.com, a global news source and investor resource covering cannabis
and hemp stocks issues a sector news alert on companies with new drug
discoveries and developments in the sector.

Investorideas.com - #Cannabis Stock News; Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Division to Begin Human Trials of Its Lead #Cannabis Strain for Pain; @VeritasPharma

Investorideas.com - #Cannabis Stock News; Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Division to Begin Human Trials of Its Lead #Cannabis Strain for Pain; @VeritasPharma

Research
Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto
Rico

Vancouver, B.C. - November 21, 2017
(Investorideas.com Newswire) Veritas Pharma Inc.- Cannabis and Biopharma News
alert -  (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), ("Veritas" or the
"Company") reports  that its research arm, Cannevert
Therapeutics Ltd. ("CTL") has signed a letter of intent with the
Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first
human study of CTL-X, its lead cannabis strain targeting pain.

Investorideas.com - Investor Ideas Adds $SOGO, $HX, $AQUA, $FNKO, $LOMA, $IFRX, $FEDU $APLS to Directories

Investorideas.com - Investor Ideas Adds $SOGO, $HX, $AQUA, $FNKO, $LOMA, $IFRX, $FEDU $APLS to Directories

Investorideas.com, a global news source and
investor resource covering actively traded sectors announces this week’s
additions to its global stock directories in tech, biotech,
China-Asia, homebuilder, toy, renewable energy, water, mining & gaming.

Biotech Stocks added; (CSE:CBP), (NasdaqGS:SPRO),(NasdaqGS:ALNA)

Investorideas.com - Investor Ideas Adds #Tech #Stocks: $UBS, $AQ, $ALTR, $ACMR

Investor Ideas Adds #Tech
#Stocks; $UBS, $AQ, $ALTR, $ACMR

Mining Stocks added; (CSE:TUSK), (CSE:SUV),
(TSX:LBY.V),(CSE:DST)

Biotech Stocks added; (CSE:CBP),
(NasdaqGS:SPRO),(NasdaqGS:ALNA) 

Point Roberts, WA, Delta BC – November 10, 2017 –
Investorideas.com, a global news source and investor resource covering actively
traded sectors announces this week’s additions to its global stock
directories in tech, mining, biotech & gaming.

Investorideas.com - #Biopharma Stock News: Otonomy (NASDAQ: $OTIC) Third Quarter 2017 Financial Results and Corporate Update

Investorideas.com - #Biopharma Stock News: Otonomy (NASDAQ: $OTIC) Third Quarter 2017 Financial Results and Corporate Update

Investorideas.com - #Biopharma Stock News: Sage Therapeutics (NASDAQ: $SAGE) Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression

Investorideas.com - #Biopharma Stock News: Sage Therapeutics (NASDAQ: $SAGE) Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression